The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The opposing roles of Wnt-5a in cancer
Open accessAbstract
Wnt-5a is one of the most highly investigated non-canonical Wnts and has been implicated in almost all aspects of non-canonical Wnt signalling. In terms of cancer development, Wnt-5a has, until recently, lived in the shadow of its better-characterised relatives. This was largely because of its apparent inability to transform cells or signal through the canonical beta-catenin pathway that is so important in cancer, particularly colorectal cancer. Recent work in a wide range of human tumours has pointed to a critical role for Wnt-5a in malignant progression, but there is conflicting evidence whether Wnt-5a has a tumour-promoting or -suppressing role. Emerging evidence suggests that the functions of Wnt-5a can be drastically altered depending on the availability of key receptors. Hence, the presence or absence of these receptors may go some way to explain the conflicting role of Wnt-5a in different cancers. This review summarises our current understanding of Wnt-5a and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Caught up in a Wnt storm: Wnt signaling in cancer
Giles, R. H., van Es, J. H., & Clevers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00005-2 · Cited by 1,482
Veeman, M. T., Axelrod, J. D., & Moon, R. T. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00266-1 · Cited by 1,359
Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context
Mikels, A. J., & Nusse, R. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040115 · Cited by 1,252
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma
Weeraratna, A. T., Jiang, Y., Hostetter, G., Rosenblatt, K., Duray, P., Bittner, M., & Trent, J. M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00045-4 · Cited by 959
Kühl, M., Sheldahl, L. C., Park, M., Miller, J. R., & Moon, R. T. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02028-x · Cited by 861
The receptor tyrosine kinase Ror2 is involved in non‐canonical Wnt5a/JNK signalling pathway
Oishi, I., Suzuki, H., Onishi, N., Takada, R., Kani, S., Ohkawara, B., Koshida, I., Suzuki, K., Yamada, G., Schwabe, G. C., et al. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00662.x · Cited by 780
Slusarski, D. C., Corces, V. G., & Moon, R. T. (1997) · Nature · doi:10.1038/37138 · Cited by 680 · cited 2×
“Some of the earliest experiments carried out in Xenopus embryos showed that Xenopus Wnt-5A (Xwnt-5A) was able to activate Rat (r) FZ-2, resulting in intracellular Ca2þ release (Slusarski et al, 1997b).”
BackgroundWallingford, J. B., Fraser, S. E., & Harland, R. M. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00197-1 · Cited by 613
Ishitani, T., Kishida, S., Hyodo-Miura, J., Ueno, N., Yasuda, J., Waterman, M., Shibuya, H., Moon, R. T., Ninomiya-Tsuji, J., & Matsumoto, K. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.131-139.2003 · Cited by 541
Brannon, M., Gomperts, M., Sumoy, L., Moon, R. T., & Kimelman, D. (1997) · Genes & Development · doi:10.1101/gad.11.18.2359 · Cited by 522
Kühl, M., Sheldahl, L. C., Malbon, C. C., & Moon, R. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12701 · Cited by 517
Kurayoshi, M., Oue, N., Yamamoto, H., Kishida, M., Inoue, A., Asahara, T., Yasui, W., & Kikuchi, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2359 · Cited by 451
Wnt5a functions in planar cell polarity regulation in mice
Qian, D., Jones, C., Rzadzinska, A., Mark, S., Zhang, X., Steel, K. P., Dai, X., & Chen, P. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.03.011 · Cited by 427
Transformation by Wnt family proteins correlates with regulation of beta-catenin.
Shimizu, H., Julius, M. A., Giarrè, M., Zheng, Z., Brown, A. M. C., & Kitajewski, J. (1997) · PubMed · Cited by 409
Torres, M. A., Yang-Snyder, J. A., Purcell, S. M., DeMarais, A. A., McGrew, L. L., & Moon, R. T. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.5.1123 · Cited by 405
Modulation of Embryonic Intracellular Ca2+Signaling byWnt-5A
Slusarski, D. C., Yang-Snyder, J., Busa, W. B., & Moon, R. T. (1997) · Developmental Biology · doi:10.1006/dbio.1996.8463 · Cited by 404 · cited 2×
“Some of the earliest experiments carried out in Xenopus embryos showed that Xenopus Wnt-5A (Xwnt-5A) was able to activate Rat (r) FZ-2, resulting in intracellular Ca2þ release (Slusarski et al, 1997b).”
BackgroundDissanayake, S. K., Wade, M., Johnson, C. E., O'Connell, M. P., Leotlela, P. D., French, A. D., Shah, K. V., Hewitt, K. J., Rosenthal, D. T., Indig, F. E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700075200 · Cited by 374
Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines
Pukrop, T., Klemm, F., Hagemann, T., Gradl, D., Schulz, M., Siemes, S., Trümper, L., & Binder, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509703103 · Cited by 363
SnapShot: Noncanonical Wnt Signaling Pathways
Semenov, M. V., Habas, R., MacDonald, B. T., & He, X. (2007) · Cell · doi:10.1016/j.cell.2007.12.011 · Cited by 353
Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos
Sheldahl, L. C., Slusarski, D. C., Pandur, P., Miller, J. R., Kühl, M., & Moon, R. T. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211094 · Cited by 350
Mlodzik, M. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02770-1 · Cited by 341
Chien, A. J., Moore, E. C., Lonsdorf, A. S., Kulikauskas, R. M., Rothberg, B. G., Berger, A. J., Major, M. B., Hwang, S. T., Rimm, D. L., & Moon, R. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811902106 · Cited by 332
Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue
Liang, H., Chen, Q., Coles, A. H., Anderson, S. J., Pihan, G., Bradley, A., Gerstein, R., Jurecic, R., & Jones, S. N. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00268-x · Cited by 329
Du, S. J., Purcell, S. M., Christian, J. L., McGrew, L. L., & Moon, R. T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2625 · Cited by 314
Wnt-5a has tumor suppressor activity in thyroid carcinoma
Kremenevskaja, N., von Wasielewski, R., Rao, A. S., Schöfl, C., Andersson, T., & Brabant, G. (2005) · Oncogene · doi:10.1038/sj.onc.1208370 · Cited by 260
Witze, E. S., Litman, E. S., Argast, G. M., Moon, R. T., & Ahn, N. G. (2008) · Science · doi:10.1126/science.1151250 · Cited by 244
Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.
Jönsson, M., Dejmek, J. S., Bendahl, P., & Andersson, T. (2002) · PubMed · Cited by 212
Nomachi, A., Nishita, M., Inaba, D., Enomoto, M., Hamasaki, M., & Minami, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802325200 · Cited by 211
Ying, J., Li, H., Yu, J., Ng, K. M., Poon, F. F., Wong, S. C. C., Chan, A. T. C., Sung, J. J. Y., & Tao, Q. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1644 · Cited by 193
Dejmek, J., Dejmek, A., Säfholm, A., Sjölander, A., & Andersson, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1710 · Cited by 186
Ripka, S., Konig, A., Buchholz, M., Wagner, M., Sipos, B., Kloppel, G., Downward, J., Gress, T., & Michl, P. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl255 · Cited by 172
WNT5A Expression Increases during Melanoma Progression and Correlates with Outcome
Da Forno, P. D., Pringle, J. H., Hutchinson, P., Osborn, J., Huang, Q., Potter, L., Hancox, R. A., Fletcher, A., & Saldanha, G. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5104 · Cited by 170
Planar cell polarity signaling in vertebrates
Jones, C., & Chen, P. (2007) · BioEssays · doi:10.1002/bies.20526 · Cited by 166
Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer
Wang, Q., Williamson, M., Bott, S., Brookman-Amissah, N., Freeman, A., Nariculam, J., Hubank, M. J. F., Ahmed, A., & Masters, J. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210472 · Cited by 165
Huang, C.-L., Liu, D., Nakano, J., Ishikawa, S., Kontani, K., Yokomise, H., & Ueno, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2871 · Cited by 165
MacLeod, R. J., Hayes, M. N., & Pacheco, I. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00119.2007 · Cited by 164
New Regulators of Wnt/β-Catenin Signaling Revealed by Integrative Molecular Screening
Major, M. B., Roberts, B. S., Berndt, J. D., Marine, S., Anastas, J. N., Chung, N., Ferrer, M., Yi, X., Stoick-Cooper, C. L., von Haller, P. D., et al. (2008) · Science Signaling · doi:10.1126/scisignal.2000037 · Cited by 159
Cleton-Jansen, A. (2001) · Breast Cancer Research · doi:10.1186/bcr416 · Cited by 133
Säfholm, A., Tuomela, J. M., Rosenkvist, J., Dejmek, J. S., Härkönen, P. L., & Andersson, T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0711 · Cited by 124
Dejmek, J. S., Leandersson, K., Manjer, J., Bjartell, A. S., Emdin, S. O., Vogel, W. F., Landberg, G., & Andersson, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.520.11.2 · Cited by 120
Mitogen-activated Protein Kinase p38 Regulates the Wnt/Cyclic GMP/Ca2+ Non-canonical Pathway
Ma, L., & Wang, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702840200 · Cited by 103
Low expression of Wnt-5a gene is associated with high-risk neuroblastoma
Blanc, É., Roux, G. L., Bénard, J., & Raguénez, G. (2004) · Oncogene · doi:10.1038/sj.onc.1208255 · Cited by 91
Román‐Gómez, J., Jiménez‐Velasco, A., Cordeu, L., Vilas‐Zornoza, A., José‐Eneriz, E. S., Gárate, L., Castillejo, J. A., Martin, V., Prósper, F., Heiniger, A., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.10.004 · Cited by 82
Medrek, C., Landberg, G., Andersson, T., & Leandersson, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804923200 · Cited by 81
Winkel, A., Stricker, S., Tylżanowski, P., Seiffart, V., Mundlos, S., Groß, G., & Hoffmann, A. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.08.009 · Cited by 66
Anti-apoptotic action of Wnt5a in dermal fibroblasts is mediated by the PKA signaling pathways
Torii, K., Nishizawa, K., Kawasaki, A., Yamashita, Y., Katada, M., Ito, M., Nishimoto, I., Terashita, K., Aiso, S., & Matsuoka, M. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.02.013 · Cited by 65
Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma
Liu, X. H., Pan, M., Zhou, L., Wu, B., Rao, Q., Zhou, Z., & Zhou, X. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.12.011 · Cited by 42
The Potential for Targeting Oncogenic WNT/β -Catenin Signaling in Therapy
Ewan, K., & Dale, T. C. (2008) · Current Drug Targets · doi:10.2174/138945008784911787 · Cited by 30
Convergent extension and the hexahedral cell
Green, J. B. A., & Davidson, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb438 · Cited by 28
Cited by
Wnt/Ca2+ signaling pathway: a brief overview
De, A. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr079 · Cited by 523
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
White, B. D., Chien, A. J., & Dawson, D. W. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.001 · Cited by 469
Wnt-Frizzled/Planar Cell Polarity Signaling: Cellular Orientation by Facing the Wind (Wnt)
Yang, Y., & Mlodzik, M. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125315 · Cited by 375
Fuxe, J., Vincent, T., & Garcia de Herreros, A. (2010) · Cell Cycle · doi:10.4161/cc.9.12.12050 · Cited by 311
Wnt/β-catenin signalling in prostate cancer
Kypta, R. M., & Waxman, J. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.116 · Cited by 275
Metadata
- Authors
- McDonald, S. L., & Silver, A.
- Venue
- British Journal of Cancer
- Published
- 2009-07
- Volume
- 101
- Issue
- 2
- Pages
- 209-214
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2088926937
- Cited by
- 260
- References
- 49
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.